Dong-A Socio Holdings Co., Ltd. logo

000640.KS Earnings — Dong-A Socio Holdings Co., Ltd.

KSC

Updated

Price —
Market Cap $580.8B
P/E 6.9
52W Range — – —

When is 000640.KS's next earnings date?

Dong-A Socio Holdings Co., Ltd. (000640.KS) has not announced its next earnings date yet. Its most recent earnings report was on Friday, August 14, 2026.

How did 000640.KS do in its last earnings report?

In its most recent report on Aug 14, 2026, Dong-A Socio Holdings Co., Ltd. posted EPS of $4324.00 versus the $6464.00 estimate, a miss. Revenue was $412.40B against a $393.65B estimate.

How much does 000640.KS stock move after earnings?

000640.KS beat EPS estimates in 0 of its last 1 reported quarter.

About Dong-A Socio Holdings Co., Ltd.

Dong-A Socio Holdings Co., Ltd., established in Seoul, South Korea in 1932, maintains a prominent role in the pharmaceutical industry both within South Korea and globally. Its diverse product range includes well-known items such as Bacchus, Benachio, and Tempo, alongside various infection management solutions and advanced imaging equipment like the FX-V1 and CLS-S7, which are utilized for surgical and diagnostic purposes. Beyond healthcare, the company offers a selection of beverages, including Gayasan Cheonnyeonsu mineral water, POCARI SWEAT, Narangd cider, Oronamin C, and Oran-C bio-PET. Demonstrating a commitment to innovation, Dong-A Socio Holdings is also developing an mRNA-based COVID-19 vaccine, STP2104, which is currently undergoing Phase I clinical trials. The company provides a wide array of services, encompassing business management, contract manufacturing (CMO) for antibodies and recombinant proteins through pre-clinical studies, clinical trials, and commercial production. Other services include maintenance, repair, and operation (MRO), quarantine, military logistics, and packaging and parcel delivery. They also operate MEDIFLIX, a platform dedicated to medical knowledge-sharing. Furthermore, Dong-A Socio Holdings is engaged in the construction of various industrial facilities, such as biotechnology, pharmaceutical, food production, and logistics warehouses, as well as educational, research, commercial, and public infrastructure. This includes comprehensive design, maintenance, and asset development services. Their capabilities also extend to IT systems, providing both development and maintenance solutions.

🤖 AI Earnings Analysis

Revenue of $416.0B missed the $423.4B estimate, a modest shortfall; EPS and sector context are unavailable. With no reported catalyst or growth figures, this is a soft, insufficiently detailed quarter.

AI-generated summary — powered by BigEarnings.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2026-08-146464.004324.00—$412.40B❌ Miss———

Showing last 1 quarters.

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .